Viewing StudyNCT00300287



Ignite Creation Date: 2024-05-05 @ 4:44 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00300287
Status: COMPLETED
Last Update Posted: 2017-08-02
First Post: 2006-03-06

Brief Title: A 56-Week Extension to a Clinical Study to Assess the Efficacy and Safety of Vildagliptin Compared to Placebo in Drug Naive Patients With Type 2 Diabetes and Mild Hyperglycemia
Sponsor: Novartis
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Diabetes Mellitus Type 2
Keywords:
Name View
Vildagliptin View
Type 2 diabetes View